Cite
Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab.
MLA
Nixon, Donald R., and Nicholas AP Flinn. “Evaluation of Contrast Sensitivity and Other Visual Function Outcomes in Diabetic Macular Edema Patients Following Treatment Switch to Aflibercept from Ranibizumab.” Clinical Ophthalmology, vol. 12, Jan. 2018, pp. 191–97. EBSCOhost, https://doi.org/10.2147/OPTH.S158268.
APA
Nixon, D. R., & Flinn, N. A. (2018). Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab. Clinical Ophthalmology, 12, 191–197. https://doi.org/10.2147/OPTH.S158268
Chicago
Nixon, Donald R, and Nicholas AP Flinn. 2018. “Evaluation of Contrast Sensitivity and Other Visual Function Outcomes in Diabetic Macular Edema Patients Following Treatment Switch to Aflibercept from Ranibizumab.” Clinical Ophthalmology 12 (January): 191–97. doi:10.2147/OPTH.S158268.